TCN e-Systems

Case Studies

Speeding the Development of Global Recruitment Materials

Ideal Site Selection

Optimizing Site and Monitor Performance

Forward to a Colleague

To send this information to a colleague, click here.

Learn More

Contact Us

Optimizing Site and Monitor Performance

Despite numerous competing studies (some of which were being conducted by the sites themselves) all that the monitors and site staffs needed to facilitate the on time enrollment of this type 2 diabetes study were just three of our six product suites, plus access to the TCN e-Systems Resource Library.


Study

  • Phase III
  • 65 U.S. sites
  • 750 patients


Objectives

  • Enroll all 750 patients within 6 months.
  • The sponsor's study team also wanted to surpass the company-wide average of 0.5 enrolled patients/site/week in this therapeutic area.


Recruitment Challenges

  • Original sponsor expectations were that monitors would be able to aid the sites in implementing and tracking recruitment, enrollment, and randomization efforts. Once the study began, however, it was clear that crucial recruitment-focused tasks were not being completed.


Toolkit

Product Suite
Essential Use
Learn More
TrialCENTRALNet For centralized tracking of each site's recruitment and enrollment performance. Learn More >
SiteOPTIMIZER For determining the specific levels of need and efficient training of both monitors and site staff. Learn More >
Resource Library For empowering monitors and site staff with regularly distributed recruitment tips and techniques pertinent to the challenges encountered. Learn More >
RetentionBOOSTER For dissemination of milestone reminders, and exchange of recruitment problems and solutions by individual sites. Learn More >



Results

  • Monitor effectiveness improved dramatically when provided with the e-recruitment tools.
  • Sites received the specific recruitment assistance they needed.
  • The entire study community benefited from open communication channels used to identify and solve common recruitment barriers across sites.
  • The sponsor team received specific metrics on front-line, real-time recruitment progress that proved they raised the average to .67 enrolled patients/site/week and enrolled the study slightly ahead of schedule.




[ back to top ]